CVE-2017-17678: Bmc Remedy Mid-Tier

Medium severity, CVSS 6.1. EPSS: 0.6% chance of exploitation in the next 30 days.

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Affected products

• Bmc Remedy Mid-Tier: version 9.1 only

Published 2021-05-19. Last modified 2026-07-09.